Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

5ZIB

Crystal structure of human GnT-V luminal domain in apo form

Summary for 5ZIB
Entry DOI10.2210/pdb5zib/pdb
Related5ZIC
DescriptorAlpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase A, 2-acetamido-2-deoxy-beta-D-glucopyranose (3 entities in total)
Functional Keywordsglycosyltransferase cancer metastasis luminal protein, sugar binding protein
Biological sourceHomo sapiens (Human)
Total number of polymer chains1
Total formula weight71807.45
Authors
Nagae, M.,Yamaguchi, Y. (deposition date: 2018-03-14, release date: 2018-08-01, Last modification date: 2024-10-09)
Primary citationNagae, M.,Kizuka, Y.,Mihara, E.,Kitago, Y.,Hanashima, S.,Ito, Y.,Takagi, J.,Taniguchi, N.,Yamaguchi, Y.
Structure and mechanism of cancer-associated N-acetylglucosaminyltransferase-V.
Nat Commun, 9:3380-3380, 2018
Cited by
PubMed Abstract: N-acetylglucosaminyltransferase-V (GnT-V) alters the structure of specific N-glycans by modifying α1-6-linked mannose with a β1-6-linked N-acetylglucosamine branch. β1-6 branch formation on cell surface receptors accelerates cancer metastasis, making GnT-V a promising target for drug development. However, the molecular basis of GnT-V's catalytic mechanism and substrate specificity are not fully understood. Here, we report crystal structures of human GnT-V luminal domain with a substrate analog. GnT-V luminal domain is composed of a GT-B fold and two accessary domains. Interestingly, two aromatic rings sandwich the α1-6 branch of the acceptor N-glycan and restrain the global conformation, partly explaining the fine branch specificity of GnT-V. In addition, interaction of the substrate N-glycoprotein with GnT-V likely contributes to protein-selective and site-specific glycan modification. In summary, the acceptor-GnT-V complex structure suggests a catalytic mechanism, explains the previously observed inhibition of GnT-V by branching enzyme GnT-III, and provides a basis for the rational design of drugs targeting N-glycan branching.
PubMed: 30140003
DOI: 10.1038/s41467-018-05931-w
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

226707

PDB entries from 2024-10-30

PDB statisticsPDBj update infoContact PDBjnumon